Works matching IS 09509232 AND DT 2010 AND VI 29 AND IP 46

Results: 10

The CASPR2 cell adhesion molecule functions as a tumor suppressor gene in glioma.

Published in:

Oncogene, 2010, v. 29, n. 46, p. 6138, doi. 10.1038/onc.2010.342

By:

Bralten, L B C;
Gravendeel, A M;
Kloosterhof, N K;
Sacchetti, A;
Vrijenhoek, T;
Veltman, J A;
van den Bent, M J;
Kros, J M;
Hoogenraad, C C;
Sillevis Smitt, P A E;
French, P J

Publication type:

Article

Trisomy 21 leukemias: finding the hits that matter.

Published in:

Oncogene, 2010, v. 29, n. 46, p. 6099, doi. 10.1038/onc.2010.353

By:

Rabson, A B

Publication type:

Article

Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population.

Published in:

Oncogene, 2010, v. 29, n. 46, p. 6115, doi. 10.1038/onc.2010.350

By:

Fukunaga-Kalabis, M;
Martinez, G;
Nguyen, T K;
Kim, D;
Santiago-Walker, A;
Roesch, A;
Herlyn, M

Publication type:

Article

TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells.

Published in:

Oncogene, 2010, v. 29, n. 46, p. 6172, doi. 10.1038/onc.2010.340

By:

Marshall, G M;
Bell, J L;
Koach, J;
Tan, O;
Kim, P;
Malyukova, A;
Thomas, W;
Sekyere, E O;
Liu, T;
Cunningham, A M;
Tobias, V;
Norris, M D;
Haber, M;
Kavallaris, M;
Cheung, B B

Publication type:

Article

Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down's syndrome.

Published in:

Oncogene, 2010, v. 29, n. 46, p. 6102, doi. 10.1038/onc.2010.351

By:

De Vita, S;
Canzonetta, C;
Mulligan, C;
Delom, F;
Groet, J;
Baldo, C;
Vanes, L;
Dagna-Bricarelli, F;
Hoischen, A;
Veltman, J;
Fisher, E M C;
Tybulewicz, V L J;
Nizetic, D

Publication type:

Article

Status of p53 in human cancer cells does not predict efficacy of CHK1 kinase inhibitors combined with chemotherapeutic agents.

Published in:

Oncogene, 2010, v. 29, n. 46, p. 6149, doi. 10.1038/onc.2010.343

By:

Zenvirt, S;
Kravchenko-Balasha, N;
Levitzki, A

Publication type:

Article

The centrosomal protein TACC3 controls paclitaxel sensitivity by modulating a premature senescence program.

Published in:

Oncogene, 2010, v. 29, n. 46, p. 6184, doi. 10.1038/onc.2010.354

By:

Schmidt, S;
Schneider, L;
Essmann, F;
Cirstea, I C;
Kuck, F;
Kletke, A;
Jänicke, R U;
Wiek, C;
Hanenberg, H;
Ahmadian, M R;
Schulze-Osthoff, K;
Nürnberg, B;
Piekorz, R P

Publication type:

Article

Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes.

Published in:

Oncogene, 2010, v. 29, n. 46, p. 6085, doi. 10.1038/onc.2010.407

By:

Al-Ejeh, F;
Kumar, R;
Wiegmans, A;
Lakhani, S R;
Brown, M P;
Khanna, K K

Publication type:

Article

YAP dysregulation by phosphorylation or ΔNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets.

Published in:

Oncogene, 2010, v. 29, n. 46, p. 6160, doi. 10.1038/onc.2010.339

By:

Ehsanian, R;
Brown, M;
Lu, H;
Yang, X P;
Pattatheyil, A;
Yan, B;
Duggal, P;
Chuang, R;
Doondeea, J;
Feller, S;
Sudol, M;
Chen, Z;
Van Waes, C

Publication type:

Article

Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair.

Published in:

Oncogene, 2010, v. 29, n. 46, p. 6125, doi. 10.1038/onc.2010.345

By:

Tian, L;
Peng, G;
Parant, J M;
Leventaki, V;
Drakos, E;
Zhang, Q;
Parker-Thornburg, J;
Shackleford, T J;
Dai, H;
Lin, S-Y;
Lozano, G;
Rassidakis, G Z;
Claret, F X

Publication type:

Article